Stock Events

Stock Events

CSL 

$24.54
556
+$0.52+2.16% Tuesday 19:53

Statistics

Day High
24.54
Day Low
24.08
52W High
44.86
52W Low
22.83
Volume
85,155
Avg. Volume
410,501
Mkt Cap
11.83B
P/E Ratio
18.71
Dividend Yield
4.3%
Dividend
1.06

Upcoming

16
APR
Dividend Payment
Increased
 
10
SEP
Dividend Ex
Estimated
 
9
OCT
Dividend Payment
Estimated
 
11
MAR 27
Dividend Ex
Estimated
 
16
APR 27
Dividend Payment
Estimated
 

Dividends

4.3%Dividend Yield
Apr 26
$0.65
Oct 25
$0.41
Apr 25
$0.33
Oct 24
$0.36
Apr 24
$0.3
10Y Growth
12.52%
5Y Growth
13.71%
3Y Growth
21.38%
1Y Growth
44.52%

Earnings

10FebExpected
Q4 2022
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
0.04
2.37
4.7
7.04
Expected EPS
5.85283098890224
Actual EPS
5.69732098678165

Financials

19.46%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
30.86BRevenue
6BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CSLLY. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with CSL in the development and marketing of medications and vaccines for various diseases.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, competing with CSL, particularly in the immunology and blood-related product markets.
Novo Nordisk
NVO
Mkt Cap217.54B
Novo Nordisk is a leading global healthcare company that competes with CSL in the area of biopharmaceuticals, particularly in treatments for hemophilia and other disorders.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global biopharmaceutical company focused on human health, competing with CSL in areas such as rare diseases, vaccines, and immune disorders.
Baxter International
BAX
Mkt Cap9.49B
Baxter International develops, manufactures, and markets products that save and sustain the lives of people, directly competing with CSL in the plasma-derived therapies and critical care products.
Takeda Pharmaceutical
TAK
Mkt Cap42.62B
Takeda Pharmaceutical Company focuses on oncology, gastroenterology, neuroscience, and rare diseases, competing with CSL in the plasma-derived therapy market and other areas.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a pioneer in healthcare, competing with CSL in the biotechnology and pharmaceuticals sectors, especially in diagnostics and treatments for various diseases.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in the pharmaceuticals sector, competing with CSL in the development and marketing of advanced therapies for various diseases, including immunology and oncology.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a global healthcare company that competes with CSL in the pharmaceutical and healthcare sector, focusing on vaccines, pharmaceuticals, and consumer healthcare products.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company that competes with CSL in the development of innovative therapeutics in areas such as cardiovascular disease, oncology, and bone health.

About

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Show more...
CEO
Dr. Paul F. McKenzie Ph.D.
Employees
32698
Country
AU
ISIN
US12637N2045

Listings

MX
MX
CSLN.MX
F
DE
CSJ.F
F
DE
CSJA.F
OTC Link
US
CMXHF

0 Comments

Share your thoughts

FAQ

What is CSL stock price today?▼
The current price of CSLLY is $24.54 USD — it has increased by +2.16% in the past 24 hours. Watch CSL stock price performance more closely on the chart.
What is CSL stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange CSL stocks are traded under the ticker CSLLY.
Is CSL stock price growing?▼
CSLLY stock has fallen by -0.49% compared to the previous week, the month change is a -5.61% fall, over the last year CSL has showed a -38.21% decrease.
What is CSL market cap?▼
Today CSL has the market capitalization of 11.83B
When is the next CSL earnings date?▼
CSL is going to release the next earnings report on August 18, 2026.
What were CSL earnings last quarter?▼
CSLLY earnings for the last quarter are 4.03 USD per share, whereas the estimation was 4.14 USD resulting in a -2.66% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is CSL revenue for the last year?▼
CSL revenue for the last year amounts to 30.86B USD.
What is CSL net income for the last year?▼
CSLLY net income for the last year is 6B USD.
Does CSL pay dividends?▼
Yes, CSLLY dividends are paid semi-annual. The last dividend per share was 0.41 USD. As of today, Dividend Yield (FWD)% is 4.3%.
How many employees does CSL have?▼
As of April 01, 2026, the company has 32,698 employees.
In which sector is CSL located?▼
CSL operates in the Health Care sector.
When did CSL complete a stock split?▼
The last stock split for CSL was on March 02, 2026 with a ratio of 2:1.
Where is CSL headquartered?▼
CSL is headquartered in Melbourne, AU.